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 COPD, a major cause of morbidity and mortality worldwide, 1 is believed to result from an abnor-
mal pulmonary infl ammatory response to noxious 
particles or gases. 2 Clinically, the disease is defi ned by 
GOLD (Global Initiative for the Obstructive Lung 
Disease) as the presence of airway obstruction deter-
mined by a postbronchodilator FEV 1 /FVC  , 0.70. 
Although emphysema is not part of the defi nition, the 
GOLD report does mention chronic airway disease 
and emphysema as different components of COPD, 
with varying degrees of each in individual patients. 2 
Emphysema is anatomically defi ned as an abnormal 
permanent enlargement of the airspace distal to the 
terminal bronchioles, accompanied by destruction of 
their walls without obvious fi brosis. 3 
 Background:  Phenotypic characterization of patients with COPD may have potential prognostic 
and therapeutic implications. Available information on the relationship between emphysema and 
the clinical presentation in patients with COPD is limited to advanced stages of the disease. The 
objective of this study was to describe emphysema presence, severity, and distribution and its 
impact on clinical presentation of patients with mild to moderate COPD. 
 Methods:  One hundred fi fteen patients with COPD underwent clinical and chest CT scan evalua-
tion for the presence, severity, and distribution of emphysema. Patients with and without emphy-
sema and with different forms of emphysema distribution (upper/lower/core/peel) were compared. 
The impact of emphysema severity and distribution on clinical presentation was determined. 
 Results:  Fifty percent of the patients had mild homogeneously distributed emphysema 
(1.84; 0.76%-4.77%). Upper and core zones had the more severe degree of emphysema. Patients with 
emphysema were older, more frequently men, and had lower FEV 1 %, higher total lung capacity 
percentage, and lower diffusing capacity of the lung for carbon monoxide. No differences were 
found between the clinical or physiologic parameters of the different emphysema distributions. 
 Conclusions:  In patients with mild to moderate COPD, although the presence of emphysema has 
an impact on physiologic presentation, its severity and distribution seem to have little impact on 
clinical presentation.  CHEST 2011; 139(1):36–42 
 Abbreviations:  6MWD  5 6-min walking distance; BODE  5 BMI, obstruction, dyspnea, and exercise capacity; 
 Dlco  5 diffusing capacity of the lung for carbon monoxide; GOLD  5 Global Initiative for Obstructive Lung Disease; 
HU  5 Hounsfi eld units; IC  5 inspiratory capacity; LAA  5 low-attenuation areas; MMRC  5 Modifi ed Medical Research 
Council Dyspnea Scale; TLC  5 total lung capacity 
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Linda, California) were determined following American Thoracic 
Society recommendations. 14 The European Community Lung 
Health Survey values were used as reference. 15 The 6-min walking 
distance (6MWD) was performed following current American 
Thoracic Society guidelines. 16 Dyspnea was assessed using the 
Modifi ed Medical Research Council Dyspnea Scale (MMRC). 17 
BMI was calculated as the weight in kilograms divided by height 
in meters. 2 Inspiratory capacity (IC) was measured as previously 
described. 18 The ratio between IC and total lung capacity (TLC) 
was determined from the lung volume measurements. The BODE 
index (BMI, obstruction, dyspnea, and exercise capacity) was 
measured and staged in quartiles as previously published by 
Celli et al. 19 To determine the health-related quality of life we 
used the Spanish validated version of the St. George Respiratory 
Questionnaire. 20 An exacerbation was defi ned following the defi -
nition by Rodriguez-Roisin, 21 and exacerbation frequency was eval-
uated by patient recall over the previous year. 
 CT Scan Evaluation 
 All participants underwent single breath-hold helical CT scan 
examination of the chest at end-full-inspiration using a 64-row 
multidetector scanner (Somatom Sensation 64; Siemens Health-
care; Erlangen, Germany) with low-dose CT scan parameters 
(120 kVp, 40 mAs), 0.33s rotation time, 1.3 pitch, 32  3 0.6 mm 
detector collimation, and 64  3 0.6 mm slice acquisition by means 
of z-fl ying focal spot. 22 The CT scanner was calibrated periodi-
cally by standard methods. Slices were obtained contiguously 
from the thoracic inlet to the adrenal glands without the use of 
IV contrast material. From the raw data, 1-mm-thick sections were 
reconstructed using a soft tissue algorithm kernel (B40f). All 
CT images were transferred to a satellite console (Leonardo; 
 Siemens Healthcare) for quantitative analysis of lung attenuation. 
 Quantifi cation of Emphysema 
 Low-dose CT scan examinations were reviewed by the study 
radiologists (G. B., R. S. M.) blinded to patients’ clinical data 
and spirometry results. Images were segmented using a three-
dimensional automated image-processing software program (Lung 
Parenchyma Analysis; Siemens Healthcare; Erlangen, Germany). 23 
After initial three-dimensional segmentation of the lung, this pro-
gram automatically detects the lung contours and the airways 
based on threshold values and anatomic knowledge-based algo-
rithm without the need for manual interaction. For emphysema 
detection, a threshold value of  2 960 Hounsfi eld Units (HU) was 
used, as proposed for multidetector row CT scan examinations. 7 
From the CT scan data analysis, the volume of the segmented 
lung, the volume of the segmented emphysema, and their ratio 
(emphysema index, %LAA  2 960), were calculated automatically. 
The software also divides automatically the inner (core) and outer 
parts (peel) of lung parenchyma, the latter considered as the lung 
tissue located within 10 mm of the chest wall. Lung parenchyma 
was also divided in two parts (upper and lower) for analysis pur-
poses. The upper lung zone was defi ned as those sections above 
the main carina, and the lower lung zone was defi ned as those sec-
tions located below the main carina. The %LAA  2 960 in each 
region (upper/lower/core/peel) was calculated from the total per-
centage. Emphysema was classifi ed as upper or lower and core or 
peel zone predominant. 
 Statistical Analysis 
 Variables with normal distribution are described by their 
mean  6 SD, those with nonnormal distribution with their median 
and 25th to 50th percentiles, and categorical variables by their 
 The development of software techniques for the anal-
ysis of images obtained by CT scanning has enabled 
researchers to identify and quantify low-attenuation 
areas (LAA) in vivo that correspond to emphysema. 4 
These techniques have been validated with patho-
logic and functional correlation studies. 5-7 They have 
also been applied in different trials to determine if 
patients with COPD are candidates for lung volume 
reduction procedures (surgery, biologic glue, endo-
bronchial valves, or radiofrequency-guided bypass 
procedures) and in  a 1 -antitrypsin defi ciency trials to 
assess response to replacement therapy. 8-10 
 COPD is a heterogeneous disease with different 
phenotypes and with different clinical presentations. 11 
The presence of emphysema on CT imaging usually 
results in a greater degree of severity of COPD. 12 
Furthermore, varying distributions of emphysema in 
the lungs have been associated with different clinical 
presentations. 13 However, most of the studies that 
have used CT scan-based software analysis of emphy-
sema have been performed in populations of patients 
with severe COPD, in which emphysema causes air-
fl ow limitation through decreased elastic lung recoil 
and early airway collapse. 3 To our knowledge, there 
are no data describing the impact of emphysema 
and its distribution and severity on patients with less 
severe COPD. It is possible that the mechanisms that 
cause airfl ow limitation and determine the clinical 
presentation when the degree of lung parenchyma 
destruction is mild are different than in more severe 
disease. The aim of this study was to describe the 
impact that the presence, distribution, and severity 
of emphysema has on the clinical presentation of a 
cohort of patients with mild to moderate COPD (dys-
pnea, nutritional status, exercise capacity, exacerba-
tion rate, and quality of life). 
 Materials and Methods 
 This is a cross-sectional observational study of patients diag-
nosed with COPD recruited from July 2006 to July 2009 in the 
pulmonary clinic at the University Clinic of Navarra, a tertiary 
care medical center. Patients with all degrees of airfl ow limitation 
were included if they had smoked   20 pack-years and had a post-
bronchodilator FEV 1 /FVC of  , 0.70 after the administration of 
400  m g of inhaled albuterol. Individuals were excluded if they 
had a history of asthma, bronchiectasis, TB, or other confounding 
diseases. The patients were clinically stable (no exacerbation for 
at least 2 months) at the time of the evaluation. The study was 
approved by the institution’s ethics committee, and all patients 
signed an informed consent. 
 Clinical and Physiologic Evaluation 
 A personal interview was conducted by trained health-care 
staff recording age, sex, the presence of signifi cant comorbidities, 
smoking status, and pack-year history. Spirometry, lung volumes, 
and diffusing capacity (Vmax 22; Sensormedics Corp; Yorba 
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 Table 2 shows the differences found in the clinical 
parameters between patients with and without emphy-
sema detected by CT scan. Patients with emphysema 
were older and had higher MMRC scores. As expected, 
some physiologic parameters (ie, FEV 1 % and D lco ) 
were worse in patients with emphysema. 
 The number of women with COPD participating 
in the study was rather small (only 18), and this pre-
cludes a robust sex analysis and comparison between 
those with and without CT scan-detected emphysema. 
In any case, the percentage of emphysema tended to 
be lower in women but was not statistically different 
than in men (1.14% vs 2.16%,  P  5 .07). This may be 
because of the small number of women in the cohort, 
which also precludes analysis of differences in emphy-
sema distribution by sex. 
 Table 3 shows the univariate association between 
emphysema severity and the different clinical and 
physiologic parameters studied. Emphysema severity 
correlated with BMI, FVC%, and TLC%. A multiple 
linear regression analysis, including parameters that 
showed statistical signifi cance in the univariate analysis, 
did not fi nd statistical associations with %LAA  2 960. 
percentage. The Student  t test for independent samples was 
used to compare means of variables with normal distribution, the 
Mann-Whitney  U rank test for variables without normal distribu-
tion, and the Pearson  x 2 test for categorical variables. One-way 
analysis of variance was used to compare the four groups of emphy-
sema distribution, with Tukey post hoc testing to identify signifi -
cant differences. 
 Multiple linear regression modeling was used to test for inde-
pendent associations between clinical features with the extent 
of emphysema. Variables showing statistical signifi cance in the 
univariate analysis and potential cofounders were included in the 
multiple linear regression analysis (age, sex, pack-years, BMI, FEV 1 %, 
and diffusing capacity of the lung for carbon monoxide [D lco] ). 
 P values  , .05 were considered statistically signifi cant (software 
application SPSS version 15; SPSS, Inc; Chicago, Illinois). 
 Results 
 Two hundred thirty-six patients with COPD were 
included during the study period. We were able to 
properly register the data and perform the clinical 
and radiologic evaluation of 200 patients. Of these, 
44 subjects were not included in the fi nal cohort 
because they were found to have bronchiectasis on 
the chest CT scan. Another 41 patients were excluded 
because they had advanced-stage COPD (GOLD 
stages III or IV). Thus, the fi nal study population had 
115 patients ( Fig 1 ), whose clinical and radiologic 
characteristics are shown in  Table 1 . This predomi-
nantly male population of patients with mild to mod-
erate COPD with low BODE index scores had normal 
values of BMI and 6MWD and had a limited expres-
sion of the disease as represented by low scores in the 
MMRC and Saint George Respiratory Questionnaire 
total scores. The degree of emphysema (% LAA  2 960) 
was also low, but up to half of the population had 
radiologically detected emphysema. Emphysema was 
equally distributed in the upper and lower zones, as 
well as in core and peel zones. However, severity was 
greater in the upper and core zones. 
 Figure 1. Flow chart for the selection of the participating 
patients. GOLD  5 Global Initiative for Obstructive Lung Disease. 
 Table 1— Clinical, Physiologic, and Radiologic 
Characteristics of the Patients 
Characteristics Patients (N  5 115)
Age, y 64  6 10
Sex, male (female) 97 (18)
Pack-years history, pack-years 49  6 27
MMRC 0 (0-1)
BMI, kg/m 2 27  6 5
6MWD, m 490 (420-560)
Exacerbation in the last y, No. 0 (0-1)
SRGQ total 24  6 16
FEV 1 , % 75  6 15
FVC, % 95  6 19
FEV 1 /FVC 58  6 9
TLC, % 102  6 16
IC/TLC 43  6 11
D lco, % 73  6 20
BODE index, U 0 (0-1)
Patients with emphysema, No. (%); 
 severity, LAA  2 960 HU, %
58 (50); 1.84 (0.76-4.77)








Values are presented as mean  6 SD or median (25th-50th percentile) 
unless otherwise noted. 6MWD  5 6-min walk distance; BODE  5 BMI, 
obstruction, dyspnea, and exercise capacity; D lco  5 diffusing capacity of 
the lung for carbon monoxide; HU  5 Hounsfi eld units; IC  5 inspiratory 
capacity; LAA  5 low-attenuation areas; MMRC  5 Modifi ed Medical 
Research Council Dyspnea Scale; SGRQ  5 St. George Respiratory 
Questionnaire; TLC  5 total lung capacity.
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on the pathophysiology of this disease. Previous data 
suggest this relationship exists in patients with severe 
COPD, 13 but, to our knowledge, this association has 
not been previously reported in patients with mild to 
moderate disease and low grades of emphysema. 
 Chronic airfl ow limitation can be caused by increased 
resistance of the small conducting airways and increased 
compliance of the lung due to emphysema. 2 Tradi-
tionally, emphysema is associated with the destruction 
of alveolar walls, resulting in decreased elastic lung 
recoil and early airway collapse. 3 It has been esti-
mated that 30% of the lung must be destroyed by 
emphysema before symptoms or pulmonary func-
tion abnormalities become evident. 24 Little is known 
about the presence and impact of mild emphysema 
on patients with COPD. In this report, 50% of the 
patients with COPD included in the study have some 
degree, albeit low, of CT scan-detected emphysema. 
In these patients, the physiologic parameters of the 
disease were worse than in patients without emphy-
sema (ie, lower FEV 1 , higher TLC, and lower D lco ). 
Despite these differences, the presence of emphy-
sema had no impact on the clinical presentation of 
patients in this cohort. This is an important fi nding 
previously reported by others 12,25 in patients with a 
greater severity of COPD and emphysema. In our 
entire cohort, the mean percentage of emphysema 
was 1.84% (95% CI, 0.76%-4.77%), and even such 
small degrees of lung destruction affected the physi-
ologic presentation of COPD. It is possible that with 
such small degrees of emphysema, mechanisms other 
than changes in elastic recoil may be responsible 
for the physiologic impairment. As elegantly reported 
by Boschetto et al, 12 it is possible that patients 
with COPD who are susceptible to develop emphy-
sema respond differently to inhaled toxic substances, 
representing a more infl ammatory profi le with physi-
ologic consequences. A recently published work by 
 Clinical and physiologic characteristics of patients 
with different emphysema distributions (upper/lower/
core/peel) are shown in  Figure 2 . Although patients 
in the four groups have similar age, FEV 1 %, and BMI, 
they show a great heterogeneity in their physiologic 
and clinical presentation. 
 Discussion 
 CT scan evaluation of patients with COPD allows a 
more accurate discrimination of the emphysematous 
phenotype from other presentations of the disease. 
To our knowledge, this is the fi rst study that describes 
the presence of emphysema and its association with 
physiologic and clinical features in patients with mild 
or moderate COPD. The main fi ndings of the pres-
ent report support the theory that the presence of 
emphysema in patients with COPD has an impact 
 Table 2— Differences in Clinical and Physiologic Parameters Between Patients With COPD With and Without 
CT Scan-Detected Emphysema 
Characteristics With Emphysema (n  5 58) Without Emphysema (n  5 57)  P Value
Age, y 66  6 10 61  6 10 .02
Sex, male (female), % 39 (29) 61 (71) .021
Pack-years history, pack-years 57  6 32 51  6 28 .22
MMRC 1 (0-1) 1 (0-1) .48
BMI, kg/m 2 26  6 3 27  6 6 .15
6MWD, m 480 (420-560) 505 (431-563) .48
Exacerbation in the last year, No. 0 (0-1) 0 (0-1) .13
SRGQ total 23  6 17 25  6 16 .88
FEV 1 , % 72  6 13 77  6 16 .05
FVC, % 106  6 15 98  6 15 .005
TLC, % 103  6 17 96  6 13 .04
IC/TLC 42  6 11 43  6 12 .85
D lco, % 65  6 19 82  6 16 .001
BODE index, U 0 (1-2) 0 (0-1) .38
Values are presented as mean  6 SD or median (25th-50th percentile) unless otherwise noted. See Table 1 for expansion of abbreviations.
 Table 3— Univariate Association Between Emphysema 




Coeffi cient  P Value
Age, y 0.12 .33
Pack-years history, pack-years  2 0.52 .70
MMRC  2 0.19 .14
BMI, kg/m 2  2 0.33 .01
6MWD, m 0.18 .18
Exacerbation in the last year, No. 0.12 .24
SRGQ total  2 0.12 .39
FEV 1 , % 0.14 .27
FVC, % 0.38 .003
FEV 1 /FVC  2 0.24 .06
TLC, % 0.29 .05
IC/TLC  2 0.13 .37
D lco , % 0.03 .83
BODE index, U  2 0.08 .53
See Table 1 for expansion of abbreviations.
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that on helical multidetector row CT scan examina-
tions performed using 1.25-mm slices with soft tissue 
kernel obtained at 80 mAs, lung areas with attenua-
tion coeffi cients  ,  2 960 or  2 970 HU best refl ect the 
extent of pulmonary emphysema. 7 
 Only one study has examined the impact of the dis-
tribution of emphysema (upper/lower/core/peel) 13 
on the clinical presentation of patients with severe 
COPD. However, this has not been shown in other 
degrees of severity. Additionally, the core/peel distribu-
tion has not been proven yet to have any clinical or prog-
nostic usefulness in patients with COPD. Mair et al 13 
reported that the distribution of emphysema related 
best to the clinical presentation when divided into 
core/peel predominance. However, this effect was 
not independent of the severity of emphysema. In 
the present study, patients with COPD with mild 
to moderate disease and mild emphysema have a 
heterogeneous physiologic and clinical presentation of 
the disease according to their distribution as shown 
Papaioannou et al 26 found that patients with CT scan-
detected emphysema have higher levels of systemic 
oxidative stress and plasma fi brinogen. 
 Mair et al 13 analyzed variables that might predict 
the severity of emphysema and found that BMI was 
the best predictor. We found no link between severity 
of emphysema and BMI in our study, perhaps because 
the severity of emphysema in our cohort was mild. 
Indeed, although there was an inverse correlation 
between BMI and areas of low attenuation, individuals 
with CT scan-detected emphysema did not have lower 
BMI values. This information could challenge the 
knowledge that BMI is tightly associated with emphy-
sema, at least in patients with normal BMI and diffuse 
emphysema. Unfortunately, our cohort included few 
patients with a low BMI ( , 21), precluding a robust 
analysis of their degree of emphysema. 
 We used a three-dimensional automated method 
to quantify the degree of emphysema. A threshold of 
 2 960 was chosen based on a recent report showing 
 Figure 2. Clinical and physiologic characteristics of patients with different emphysema distribution (upper/lower/core/peel).  *Indicates a 
 P value  , .05 compared with patients without emphysema. 6MWD  5 6-min walk distance; BODE  5 BMI, obstruction, dyspnea, and exercise 
capacity; D lco  5 diffusing capacity of the lung for carbon monoxide; MRC  5 Medical Research Council Dyspnea Scale; SGRQ  5 St George 
Respiratory Questionnaire; TLC  5 total lung capacity. 
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disease or patients with preserved lung function and 
emphysema. 
 Conclusion 
 In conclusion, in this cohort of patients with mild 
to moderate COPD, the presence of emphysema, 
regardless of its distribution, has an impact on physi-
ologic parameters but not on the clinical presentation 
of the disease. Further studies should confi rm the 
importance of our fi ndings. 
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